Edition:
United States

FDA approves Medicines360's SNDA for Liletta to prevent pregnancy for up to four years


Monday, 7 Aug 2017 08:00am EDT 

Aug 7 (Reuters) - Allergan Plc :FDA approves Medicines360's SNDA for Liletta (levonorgestrel-releasing intrauterine system) 52 mg to prevent pregnancy for up to four years.Allergan Plc - ‍FDA approved Medicines360's SNDA to extend duration of use of Liletta 52 mg for prevention of pregnancy for up to four years​.